Golden Triangle Partnership

The Golden Triangle Partnership concept emerged in a National Workshop on Ayurveda Research organized at Chitrakoot from 24th to 26th May, 2003 where it was decided to set up an integrated technology mission for the development of Ayurveda and traditional medical knowledge based on synchronized working of modern medicine, traditional medicine and modern science with special budgetary support. Subsequently, in a meeting on 8th July, 2004, Secretary, Department of AYUSH, Director General, CSIR and Director General, ICMR decided to work together to achieve safe, effective and standardized classical Ayurvedic products for the identified disease conditions and to develop new Ayurvedic and herbal products effective in disease conditions of national/global importance. It was also decided to utilize appropriate technologies to develop single, poly-herbal and herbo-mineral products and to develop products which have IPR potentials.

Apex Committee of GTP Scheme in its meeting Dtd. 18.10.05 decided to include Siddha, Unani and Homeopathy in Drug development under GTP Scheme. Siddha drugs have already been identified in HIV-AIDS brainstorming sessions in this regard. As per the suggestions of the Apex committee the respective task forces should be disease specific and system neutral.

Under the GTP Scheme, Department of AYUSH, through its research Councils – Central Council for Research in Ayurveda and Siddha (CCRAS), Central Council for Research in Unani Medicines (CCRUM), Central Council for Research in Homeopathy (CCRH), – will work together with two other major partners i.e. CSIR and ICMR- to achieve the following objectives:

Objectives:

1. To bring safe, effective and standardized ASHU (Ayurveda, Siddha, Homoeopathy & Unani) products for the identified disease conditions;
2. To develop new Ayurvedic / Siddha / Unani / Homeopathic products effective in the disease conditions of national/global importance. Products should be better than the available products in the market for such disease conditions;
3. The criteria will be to have best quality, safe and effective products. Mechanism will be evolved to make products affordable for the domestic market;
4. To utilize appropriate technologies for development of single and poly-herbal products to make it globally acceptable;
5. To promote collaborative research on AYUSH with modern medicine/modern science institutions.

Time line:

All the objectives will be achieved in a mission mode in a period of five years.

Note:

At the time of inception of GTP Scheme, numbers of identified disease conditions were 12 which have now been increased to 28 in the revised scheme. In addition to this, standardization, safety toxicity studies of eight commonly used Rasayogas (Herbo-mineral/metallic preparations) are being identified for standardization and also more Rasa Yogas are to be incorporated.

Since the quantum of work is now almost double hence the total time period for implementation of all these projects would be increased in proportionate. By adding Siddha, Unani and Homoeopathy, the expenditure and duration required for the projectshall be extended as per the need.